Taiwan Faces Rising Cancer Costs: A Look at Future Trends
Taiwan’s National Health Insurance (NHI) data reveals a significant increase in cancer treatment expenditure, reaching NT$156.7 billion (US$4.89 billion) in 2025. This represents a rise of NT$26.5 billion since 2020, with an average annual growth rate of approximately 5 percent. The number of patients undergoing cancer treatment also increased to 970,104 in 2025, mirroring the 5 percent annual growth seen over the past five years.
The Leading Cancers in Taiwan
Breast cancer remains the most prevalent form of cancer diagnosed in Taiwan, accounting for 198,878 cases in 2025. Colorectal and anal cancers followed with 120,624 cases, then lung, trachea, and bronchus cancers (111,620), and prostate cancer (79,696). Notably, pancreatic cancer treatment costs have entered the top 10 for the first time in a decade.
Drivers Behind the Rising Costs
According to Huang Yu-wen, director of the NHIA’s Medical Review and Pharmaceutical Benefits Division, the increasing costs are largely attributable to Taiwan’s aging population and the expansion of cancer screening programs. These factors reflect a greater investment in healthcare and improved access to care for citizens.
Pancreatic Cancer: A Growing Concern
Pancreatic cancer presents a unique challenge. Often diagnosed at a late stage, it has limited treatment options, leading to higher costs and slower progress in drug development. The NHIA has identified a “significant treatment gap” for this disease, highlighting the require for focused attention and resources.
Government Initiatives and Future Investments
The Taiwanese government is actively increasing funding for both cancer prevention and treatment. The Health Promotion Administration has increased its cancer screening budget by approximately NT$600 million to bolster early detection efforts. Investments are also being directed towards advanced diagnostic technologies and new treatments to enhance precision care.
Digital Management and Outcome Monitoring
The NHIA is leveraging digital management systems to monitor treatment quality and outcomes. This data-driven approach aims to reduce cancer mortality and improve overall public health. Although, it’s important to note that the impact of recent investments may take three to five years to become fully measurable, with observation periods extending to 10 years for cancers requiring longer treatment cycles, such as breast cancer.
The Role of Early Detection
Early detection remains a cornerstone of cancer control. Expanded screening programs are crucial, but individual awareness and proactive health management also play a vital role. Regular check-ups and adherence to recommended screening guidelines can significantly improve outcomes.
Did you know? Taiwan’s NHI consistently ranks as one of the best healthcare systems globally, offering comprehensive coverage to its citizens.
Future Trends to Watch
Several trends are likely to shape cancer care in Taiwan in the coming years:
- Personalized Medicine: Advances in genomics and molecular diagnostics will enable more tailored treatment plans based on individual patient characteristics.
- Immunotherapy Expansion: Immunotherapy, which harnesses the body’s own immune system to fight cancer, is expected to become more widely available and effective.
- Artificial Intelligence (AI) in Diagnostics: AI-powered tools will assist in earlier and more accurate cancer detection through image analysis and data interpretation.
- Telemedicine and Remote Monitoring: Telemedicine will play an increasing role in providing cancer care, particularly for follow-up appointments and symptom management.
FAQ
Q: What is the NHI in Taiwan?
A: The National Health Insurance is Taiwan’s universal healthcare system, providing comprehensive medical coverage to residents.
Q: How is cancer treatment funded in Taiwan?
A: Cancer treatment is largely funded through the NHI, with the government increasing investment in prevention, screening, and advanced therapies.
Q: What is the six-month rule for NHI enrollment?
A: Most immigrants must reside in Taiwan for six continuous months before being eligible for NHI enrollment, unless they hold a Gold Card or specific work visas.
Q: Where can I find more information about the NHI?
A: You can visit the National Health Insurance Administration website: https://www.nhi.gov.tw/en/mp-2.html
Pro Tip: If you are new to Taiwan, familiarize yourself with the NHI system and ensure you have adequate travel health insurance during the initial six-month period.
Stay informed about cancer prevention and early detection. Discuss your risk factors with your healthcare provider and follow recommended screening guidelines.
Explore more articles on healthcare in Taiwan here. Subscribe to our newsletter for the latest updates on health and wellness.
